(1211 days)
Not Found
No
The summary describes a standard automated urinalysis system based on spectrophotometry and refractometry, with no mention of AI or ML in the device description, intended use, or performance studies.
No
The device is an in vitro diagnostic (IVD) system used to measure analytes in urine for diagnostic purposes, not to treat or mitigate disease.
Yes
The device is intended for the in vitro qualitative or semi-quantitative measurement of various analytes in urine, and the results can be used in the evaluation of kidney, urinary, liver, and other metabolic disorders, which are all diagnostic purposes.
No
The device description clearly states that the system is comprised of both a hardware component (the automated urine analyzer) and a consumable component (the test strips), in addition to any software that controls the analyzer.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states that the system is "intended for the in vitro qualitative or semi-quantitative measurement of the following analytes... in the evaluation of kidney, urinary, liver and other metabolic disorders." The term "in vitro" means "in glass" or "outside the body," which is a key characteristic of IVDs.
- Device Description: The description details how the system analyzes urine samples using test strips with chemical reagents, which react with substances in the urine. This process of analyzing a sample taken from the body to provide diagnostic information is the core function of an IVD.
- Analytes Measured: The system measures various analytes in urine (glucose, protein, bilirubin, etc.) that are used to assess health conditions. This is a typical application for IVDs in clinical laboratories.
- Care Setting and User: The system is intended for use by "trained operators in clinical laboratories," which is a common setting for IVD testing.
- Performance Studies: The document describes performance studies like method comparison and precision studies, which are standard evaluations for IVD devices to demonstrate their accuracy and reliability.
The entire description aligns with the definition and characteristics of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The AUTION MAX AX-4060 Urinalysis System (AUTION MAX) is comprised of the AUTION MAX AX-4060 automated urine analyzer and AUTION Sticks 9EB multi-parameter test strips.
The AUTION MAX AX-4060 urine analyzer, when used with AUTION Sticks 9EB test strips is a fully automated urinalysis system intended for the in vitro qualitative measurement of the following analytes: glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrite, leukocytes, turbidity, and color. The test results of these parameters can be used in the evaluation of kidney, urinary, liver and other metabolic disorders. This system is intended to be used by trained operators in clinical laboratories.
AUTION Sticks 9EB test strips are test strips for the in vitro qualitative or semi-quantitative measurement of the following analytes: glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrite, and leukocytes with the AUTION MAX AX-4060 urine analyzer. The test results of these parameters can be used in the evaluation of kidney, urinary, liver and other metabolic disorders.
Special conditions for use statements: Prescription use only. AUTION Sticks 9EB test strips are not to be read visually.
Product codes (comma separated list FDA assigned to the subject device)
JIL, JIO, KQO, CDM, JIR, JMT, LJX, JJB, CEN, JIN
Device Description
The AUTION MAX AX-4060 Urinalysis System is a fully automated urine analyzer that provides a semi-quantitative or qualitative measurement for glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrites, leukocytes, specific gravity, turbidity, and color tone. The AUTION MAX AX-4060 Urinalysis System consists of AUTION MAX AX-4060 urine analyzer and AUTION Sticks 9EB test strips.
The AUTION Sticks 9EB test strips consist of a plastic strip containing 9 dry chemistry reagent pads impregnated with chemical substances for the determination of the above analytes in urine. These substances if present in urine leads to a chemical reaction that results in a color change, which is measured by the AUTION MAX AX-4060 urine analyzer based on spectrophotometry. In addition, three additional parameters, specific gravity, turbidity, and color tone are directly measured based on reflectance refractometry, transmitted and scattered light measurements.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained operators in clinical laboratories.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Precision Study:
Study Type: Repeatability and Reproducibility testing in accordance with CLSI standard EP5-A3.
Sample Size: Not explicitly stated for each level, but results obtained from 4 operators on 3 devices with 3 lots of reagents for a minimum of 20 days.
Key Results:
- Level 1 (Negative/Normal) samples (N=120 for repeatability, N=240 for reproducibility): 99.2% to 100.0% exact match for pH, 100% exact match for all other analytes in repeatability; 99.6% to 100.0% exact match for pH, 100% exact match for all other analytes in reproducibility. All analytes showed 100% within +/- 1 CB match.
- Level 2 (High) samples (N=120 for repeatability, N=240 for reproducibility): Exact match ranged from 90.8% (PRO) to 100% (GLU, BIL, URO, BLD, NIT, LEU, TURB, Color) for repeatability; exact match ranged from 94.6% (PRO) to 100% (GLU, BIL, BLD, NIT, LEU, TURB, Color) for reproducibility. All analytes showed 100% within +/- 1 BC match.
- Level 3 (Mid) samples (N=120 for repeatability, N=240 for reproducibility): Exact match ranged from 99.2% (URO, KET) to 100% for other analytes in repeatability; exact match ranged from 99.2% (URO, KET, LEU) to 100% for other analytes in reproducibility. Most analytes showed 100% within +/- 1 BC match, with URO (99.6%) and KET (99.6%) being slightly lower for reproducibility.
Method Comparison Study:
Study Type: Agreement of results between the proposed device and the predicate device.
Sample Size: 1374 samples (1333 natural patient samples, 41 spiked samples).
Key Results:
- Overall agreement percentage for exact match ranged from 82.7% (Color tone) to 99.7% (NIT).
- Overall agreement percentage for within +/- 1 CB match was 100.0% for all analytes (GLU, PRO, BIL, URO, pH, BLD, KET, NIT, LEU, Turbidity, Color tone).
Interfering Substances Study:
Study Type: Evaluation of interfering substances influencing the accuracy of results.
Key Results:
- Identifies specific substances (Ascorbic Acid, Urobilinogen, MESNA, Sodium Bicarbonate, Specific Gravity, Hemoglobin, Bilirubin, Urine pH, Methyl-dopa) and their concentrations that showed interference above certain limits.
- Identifies therapeutic drugs and endogenous substances that showed no interference for the highest levels tested.
Limits of Detection and Sensitivity Study:
Study Type: Determination of limits of detection and minimum detection sensitivity.
Key Results: Provides minimum detection sensitivity for GLU (30 mg/dL), PRO (10 mg/dL), BIL (0.5 mg/dL), URO (2.0 mg/dL), BLD (0.023 mg/dL), KET (4.0 mg/dL), NIT (0.075 mg/dL), LEU (14 Leu/µL). Also provides detection sensitivity for each rank for all analytes.
Linearity Study:
Study Type: Evaluation of linearity for Non-strip based analytical parameters.
Key Results:
- Color tone: 100% exact match for all tested colors (54/54).
- Turbidity: 100% exact match for all ranks (60/60).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not directly reported in terms of sensitivity, specificity, PPV, NPV. Performance is reported as exact match and within +/- 1 Color Block match percentages.
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
AUTION MAX AX-4030 Fully Automated Urinalysis System (K093098), AUTION Sticks 9EB (K013783)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1340 Urinary glucose (nonquantitative) test system.
(a)
Identification. A urinary glucose (nonquantitative) test system is a device intended to measure glucosuria (glucose in urine). Urinary glucose (nonquantitative) measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, hypoglycemia, and hyperglycemia.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left side of the image is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
April 13, 2023
ARKRAY Inc. Daya Ranamukhaarachchi VP/Scientific and Regulatory Affairs 5198 West 76th Street Minneapolis, MN 55439
Re: K193514
Trade/Device Name: AUTION MAX AX-4060 Urinalysis System Regulation Number: 21 CFR 862.1340 Regulation Name: Urinary glucose (nonquantitative) test system Regulatory Class: Class II Product Code: JIL, JIO, KQO, CDM, JIR, JMT, LJX, JJB, CEN, JIN Dated: October 19, 2022 Received: October 20, 2022
Dear Daya Ranamukhaarachchi:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting of medical device-related adverse events) (21 CFR
1
- for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Paula V. Caposino -S
Paula Caposino, Ph.D. Acting Deputy Division Director Division of Chemistry and Toxicology Devices OHT7: Office of In Vitro Diagnostics Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K193514
Device Name AUTION MAX AX-4060 Urinalysis System
Indications for Use (Describe)
The AUTION MAX AX-4060 Urinalysis System (AUTION MAX) is comprised of the AUTION MAX AX-4060 automated urine analyzer and AUTION Sticks 9EB multi-parameter test strips.
The AUTION MAX AX-4060 urine analyzer, when used with AUTION Sticks 9EB test strips is a fully automated urinalysis system intended for the in vitro qualitative measurement of the following analytes: glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrite, leukocytes, turbidity, and color. The test results of these parameters can be used in the evaluation of kidney, urinary, liver and other metabolic disorders. This system is intended to be used by trained operators in clinical laboratories.
AUTION Sticks 9EB test strips are test strips for the in vitro qualitative or semi-quantitative measurement of the following analytes: glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrite, and leukocytes with the AUTION MAX AX-4060 urine analyzer. The test results of these parameters can be used in the evaluation of kidney, urinary, liver and other metabolic disorders.
Special conditions for use statements: Prescription use only. AUTION Sticks 9EB test strips are not to be read visually.
Type of Use (Select one or both, as applicable) | ||
---|---|---|
Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) | Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
5. 510(K) Summary
The 510(k) Summary is included on the following pages.
4
510(k) Summarv
This 510(k) Summary of the AUTION MAX AX-4060 Urinalysis System is submitted in compliance with 21 CFR807.92 for the purposes of safety and effectiveness.
Date Prepared: | October 19, 2022 |
---|---|
Establishment: | ARKRAY Factory Inc. |
1480 Koji, Konan-cho, | |
Koka-shi | |
Shiga Japan, 520-3306 | |
Submitter: | ARKRAY Inc. |
Yousuien-nai, 59 Gansuin-cho, Kamigyo-ku | |
Kyoto Japan, 602-0008 | |
Official US Agent: Daya Ranamukhaarachchi | |
ARKRAY Factory USA Inc. | |
VP/Scientific and Regulatory Affairs | |
Phone (408) 234-0804 | |
Fax: (952) 646-3240 | |
Email: ranamukd@arkrayusa.com | |
Primary Contact: | Daya Ranamukhaarachchi |
VP/Scientific and Regulatory Affairs | |
Phone (408) 234-0804 | |
Fax: (952) 646-3240 | |
Email: ranamukd@arkrayusa.com | |
Secondary Contact: | Dhwani Thakkar |
Regulatory Affairs Project Manager | |
Email: thakkard@arkrayusa.com | |
Phone: 437-247-1628 | |
Device Name: | |
Trade Name: | 1. AUTION MAX AX-4060 Urinalysis System |
Common Name: | 1. Automated Urinalysis System |
- Urinalysis Test Strip |
5
Predicate Device:
Regulatory Information:
Regulatory Classification for Urinalysis system and each of the tests are listed in Table 1.
| Test Description | Product
Code | Device Class | Regulation | Device Panel |
|---------------------------------------------------------------|-----------------|--------------|-----------------|---------------|
| Automated urinalysis
system | KQO | Class I | 21 CFR 862.2900 | 75 Chemistry |
| Glucose, urinary,
nonquantitative | JIL | Class II | 21 CFR 862.1340 | 75 Chemistry |
| Blood, occult,
colorimetric, in urine | JIO | Class II | 21 CFR 864.6550 | 81 Hematology |
| Urobilinogen, urinary,
non-quantitative | CDM | Class I | 21 CFR 862.1785 | 75 Chemistry |
| Protein or albumin,
urinary, nonquantitative | JIR | Class I | 21 CFR 862.1645 | 75 Chemistry |
| Nitrite, nonquantitative | JMT | Class I | 21 CFR 862.1510 | 75 Chemistry |
| Leukocyte, peroxidase
test | LJX | Class I | 21 CFR 864.7675 | 81 Hematology |
| Bilirubin and its
conjugates, urinary,
non-quantitative | JJB | Class I | 21 CFR 862.1115 | 75 Chemistry |
| pH, urinary,
nonquantitative | CEN | Class I | 21 CFR 862.1550 | 75 Chemistry |
| Ketones nonquantitative | JIN | Class I | 21 CFR 862.1435 | 75 Chemistry |
Table 1. Regulatory Classification for AUTION MAX AX-4060 Urinalysis System | ||
---|---|---|
-- | ----------------------------------------------------------------------------- | -- |
Intended Use
The AUTION MAX AX-4060 Urinalysis System (AUTION MAX) is comprised of the AUTION MAX AX-4060 automated urine analyzer and AUTION Sticks 9EB multi-parameter test strips.
The AUTION MAX AX-4060 urine analyzer, when used with AUTION Sticks 9EB test strips is a fully automated urinalysis system intended for the in vitro qualitative or semi-quantitative measurement of the following analytes: glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrite, leukocytes, turbidity, and color. The test results of these parameters can be used in the evaluation of kidney, urinary, liver and other metabolic disorders. This system is intended to be used by trained operators in clinical laboratories.
AUTION Sticks 9EB test strips are test strips for the in vitro qualitative or semi-quantitative
6
measurement of the following analytes: glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrite, and leukocytes with the AUTION MAX AX-4060 urine analyzer. The test results of these parameters can be used in the evaluation of kidney, urinary, liver and other metabolic disorders.
Special conditions for use statements: Prescription use only. AUTION Sticks 9EB test strips are not to be read visually.
Device Description
The AUTION MAX AX-4060 Urinalysis System is a fully automated urine analyzer that provides a semi-quantitative or qualitative measurement for glucose, protein, bilirubin, urobilinogen, pH, blood, ketones, nitrites, leukocytes, specific gravity, turbidity, and color tone. The AUTION MAX AX-4060 Urinalysis System consists of AUTION MAX AX-4060 urine analyzer and AUTION Sticks 9EB test strips.
The AUTION Sticks 9EB test strips consist of a plastic strip containing 9 dry chemistry reagent pads impregnated with chemical substances for the determination of the above analytes in urine. These substances if present in urine leads to a chemical reaction that results in a color change, which is measured by the AUTION MAX AX-4060 urine analyzer based on spectrophotometry. In addition, three additional parameters, specific gravity, turbidity, and color tone are directly measured based on reflectance refractometry, transmitted and scattered light measurements.
Substantial Equivalence
AUTION MAX AX-4060 Urinalysis System was developed as the successor to the predicate device AUTION MAX AX-4030 Urinalysis System. The device uses the same intendeduse claims as the predicate. The AX-4060 system utilizes the same principles and technology and shares the identical 9EB test strips for measuring the same urine analytes in a semiquantitative or qualitative manner similar to the predicate device. Some important device parts such as LED and Nozzle dispensing units were changed in the AX-4060 System due to a change in manufacturing source and the device was optimized to generate similar performance to the predicate device.
As described in the Performance Characteristics Section below, the verification and validation (bench and clinical) testing demonstrated substantial equivalence for the AX-4060 System with AUTION Sticks 9EB test strips to the predicate device. Bench testing supports that the AX-4060 System performs to meet specifications for precision, linearity, limits of detection (LOD), sensitivity, carryover and interference. Additionally, software testing, electrical safety testing and EMC testing also met performance criteria.
A list of similarities and differences between the proposed device and the predicate device is provided in Table 2.
7
Table 2. Substantial Equivalence comparison between AUTION MAX AX-406 |
---|
Urinalysis System and AUTION MAX AX-4030 Urinalysis System |
| COMPONENT/
CHARACTERISTIC | PROPOSED | PREDICATE |
---|---|---|
510(k) Number | To Be Determined | K093098 |
Device | AUTION MAX AX-4060 Urinalysis | |
System | AUTION MAX AX-4030 | |
Urinalysis System | ||
Similarities between Proposed and Predicate Devices | ||
Device Type | Automated Urinalysis System | Same |
FDA Product Code | KQO, JIL, JIO | Same |
FDA Authorized Use | Prescription Use | Same |
FDA Classification | Class II | Same |
Specimen | ||
Type/Measurement Object | Urine | Same |
Reagent | ||
(Chemical Test Strips) | AUTION Sticks 9EB | Same |
Measurement Items | GLU (Glucose), PRO (Protein), BIL | |
(Bilirubin), URO (Urobilinogen), | ||
PH (pH), BLD (Blood), KET | ||
(Ketones), NIT (Nitrite), LEU | ||
(Leukocytes), S.G. (Specific | ||
gravity), turbidity, and color tone. | Same | |
Sample Consumption | Max. 0.90 mL | Same |
Required Sample Volume | Min. 2.0 mL | Same |
Test Strip Reaction Time | Approx. 60 seconds | Same |
Test Strip Storage | Two test strip storage compartments, | |
each of which can contain different | ||
test strips | Same | |
Test Strip Storage | ||
Capacity | Maximum 200 test strips × two | |
storage compartments | Same | |
Max. Processing Speed | 225 samples/hour | Same |
Built-in Printer | 58-mm width printer paper (24 | |
digits) | Same | |
COMPONENT/ | ||
CHARACTERISTIC | PROPOSED | PREDICATE |
Memory Capacity | Normal and STAT measurements: | |
2500 tests | ||
Control measurement: 200 tests | ||
Check measurement: 50 tests | ||
Trouble list: 100 tests | Same | |
Communication System | RS-232C compliant (Switchable | |
between one-way and two-way) | Same | |
Power Requirements | 100 - 240 V AC (Maximum power | |
line fluctuation of ±10%), 50/60 Hz | Same | |
Power Input | Max. 150 VA | Same |
Intended Use | ||
Environment | For indoor use only | Same |
Measurement environment | Temperature: 10 – 30°C (50 to | |
86°F); Humidity: 30 – 60% RH | ||
(No condensation) | Same | |
Altitude | Up to 2000m (6560 feet) | Same |
Differences between Proposed and Predicate Devices | ||
Intended Use and | ||
Indications for Use | The AUTION MAX AX-4060 | |
Urinalysis System (AUTION MAX) is | ||
comprised of the AUTION MAX AX- | ||
4060 automated urine analyzer and | ||
AUTION Sticks 9EB multi-parameter | ||
test strips. |
The AUTION MAX AX-4060 urine
analyzer, when used with AUTION
Sticks 9EB test strips is a fully
automated urinalysis system intended
for the in vitro qualitative or semi-
quantitative measurement of the
following analytes: glucose, protein,
bilirubin, urobilinogen, pH, blood,
ketones, nitrite, leukocytes, turbidity,
and color. The test results of these
parameters can be used in the | The AUTION MAX AX-
4030 Urinalysis System
(AUTION MAX) is an
automated urine analyzer
intended for the in vitro
measurement of the following
analytes: glucose, protein,
bilirubin, urobilinogen, pH,
blood, ketones, nitrite,
leukocytes, specific gravity,
turbidity, and color. The
AUTION MAX is intended
for use only with AUTION
Sticks 9EB multi-parameter
test strips. |
| | other metabolic disorders. This system
is intended to be used by trained
operators in clinical laboratories. | |
| | AUTION Sticks 9EB test strips are
test strips for the in vitro qualitative or
semi-quantitative measurement of the
following analytes: glucose, protein,
bilirubin, urobilinogen, pH, blood,
ketones, nitrite, and leukocytes with
the AUTION MAX AX-4060 urine
analyzer. The test results of these
parameters can be used in the
evaluation of kidney, urinary, liver and
other metabolic disorders. | |
| | Special conditions for use statements:
Prescription use only.
AUTION Sticks 9EB test strips are
not to be read visually. | |
| Configuration | Instrument, Sampler, Hand-held
barcode reader and Accessories | Same, but the Hand-
held barcode is
optional. |
8
9
10
| COMPONENT/
CHARACTERISTIC | PROPOSED | PREDICATE |
---|---|---|
LED Wavelength | 5 LED wavelengths (450, 525, | |
562, 635 and 760 nm) | 5 LED wavelengths (430, | |
500, 565, 635, 760 nm) | ||
Warm-up Time | Max. 4 minutes | Max. 2 minutes |
Display | Large color liquid crystal display (800 | |
× 480 dots) with touch panel | Large color liquid crystal | |
display (320 × 240 dots) | ||
No touch panel | ||
External Output | 1 port (Replaceable with the | |
optional Ethernet terminal) | 2 ports (One of these ports can | |
be optionally used as an | ||
Ethernet port) | ||
Transmission Speed | RS-232C: Selectable from 300, | |
600, 1200, 2400, 4800, 9600 and | ||
19200 bps | ||
Ethernet: 10BASE-T, 100BASE- | ||
TX | RS-232C: Selectable from | |
300, 600, 1200, 2400, 4800, | ||
9600, and 19200 bps | ||
Ethernet: 10BASE-T | ||
Dimensions | 530 (W) × 530 (D) × 550 (H) mm | |
(including the sampler) | 530 (W) × 530 (D) × | |
530(H) mm | ||
(including the sampler) | ||
Weight | Instrument: Approx. 40 kg (88 lb) | |
Sampler: Approx. 4 kg (9 lb) | Instrument: approx. 37 kg | |
Sampler: approx. 4 kg | ||
Storage Environment | Temperature: -10 – 50°C (14 to | |
122°F); Humidity: 20 – 80% RH | ||
(No condensation) | Temperature: 1 – 30°C (34 to | |
86°F); | ||
Humidity: 20 – 80% RH | ||
(No condensation) | ||
Environment during | ||
Transport | Temperature: -10 – 50°C (14 to | |
122°F); Humidity: 20 – 80% RH | ||
(No condensation) | Temperature: -13 – 43°C (9 to | |
109°F); Humidity: 20 – 80% | ||
RH (No condensation) |
Test Principle:
The AUTION MAX AX-4060 urine analyzer measures analyte-specific test strips (AUTION Sticks 9EB) by dual-wavelength reflectance measurement (single wavelength for blood [BLD]). The AUTION MAX AX-4060 Urinalysis System detects urine analytes based on chemical reaction on each test pad relative to the concentration of measured analytes present in the urine sample. The chemical reaction leading to the color change that occurs on each chemical test pad is listed below.
11
PRINCIPLE |
---|
----------- |
Glucose: Glucose oxidase reaction. |
---|
------------------------------------ |
Glucose | GOD Gluconic acid + H2O2 |
---|---|
H 2 O 2 + 4-AAP + 1-Naphthol-3,6-disulfonic acid | POD Quinone imine dye (purple color) oxidation |
Protein: Protein-error reaction. |
---|
---------------------------------- |
Protein + pH indicator | acid pH indicator changes to a cyan color |
---|---|
------------------------ | ------------------------------------------------------------------------------------------------------------------------------- |
Bilirubin: Azo-coupling reaction. |
---|
----------------------------------- |
2-Methyl-5-nitroaniline + Sodium nitrite | acid Diazonium salt diazo reaction |
---|---|
Bilirubin + Diazonium salt | acid Azo dye (reddish brown color) coupling reaction |
Urobilinogen: Azo-coupling reaction. |
---|
-------------------------------------- |
Urobilinogen + Diazonium salt | acid Azo dye (reddish brown color) coupling reaction |
---|---|
------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
pH: pH indicator. |
---|
------------------- |
H + + mixed pH indicator | mixed pH indicator shows range of colors covering the urinary pH range (yellow - cyan color) |
---|---|
------------------------------------- | ---------------------------------------------------------------------------------------------- |
Blood: Activity measurement of pseudoperoxidase in hemoglobin. |
---|
---------------------------------------------------------------- |
CHP + TMBZ | hemoglobin H2O + Cumene + Oxidation dye (cyan color) pseudoperoxidase action |
---|---|
------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
Ketones: Legal reaction. |
---|
-------------------------- |
Ketones + Sodium nitroprusside | alkaline Ketones complex (purple color) |
---|---|
-------------------------------- | ----------------------------------------------------------------------------------------------------------------------------- |
Nitrite: Griess reaction. |
---|
--------------------------- |
Nitrite + Sulfanilamide | acid Diazo-compound + NEDA-2HCI |
---|---|
acid Azo dye (pink color) coupling reaction |
Leukocytes: Measurement of leukocyte esterase activity. |
---|
--------------------------------------------------------- |
TAI | esterase from leukocytes Indoxyl + MMB Azo dye (purple color) |
---|---|
hydrolysis coupling reaction |
12
Performance Characteristics
Precision
Precision study included repeatability and reproducibility testing in accordance with the CLSI standard EP5-A3. Three (3) levels of quality controls were used to attain results at negative, mid-level positive and high-positive analyte ranges. Two (2) levels of commercial controls were used to obtain the 3 levels by mixing as needed to obtain the highest and midlevel controls for testing of all the analyte ranks. Each analyte was tested using 4 operators on 3 devices combined with 3 lots of reagents for a minimum of 20 days. Results for each level are presented in Table 3, Table 4 and Table 5.
Table 3. Repeatability and Reproducibility of AUTION MAX AX-4060 Urinalysis System Combined results for Level 1 (Negative/Normal) samples
Results of all combinations | |||||
---|---|---|---|---|---|
Repeatability | |||||
(N=120) | Reproducibility | ||||
(N=240) | |||||
Analyte | Expected Result | Exact | |||
match | Within | ||||
+/- 1 CB | Exact | ||||
match | Within | ||||
+/- 1 CB | |||||
GLU | Normal | 100.0% | 100.0% | 100.0% | 100.0% |
PRO | Negative | 100.0% | 100.0% | 100.0% | 100.0% |
BIL | Negative | 100.0% | 100.0% | 100.0% | 100.0% |
URO | Normal | 100.0% | 100.0% | 100.0% | 100.0% |
pH | 5.0 | 99.2% | 100.0% | 99.6% | 100.0% |
BLD | Negative | 100.0% | 100.0% | 100.0% | 100.0% |
KET | Negative | 100.0% | 100.0% | 100.0% | 100.0% |
NIT | Negative | 100.0% | 100.0% | 100.0% | 100.0% |
LEU | Negative | 100.0% | 100.0% | 100.0% | 100.0% |
TURB | Negative | 100.0% | 100.0% | 100.0% | 100.0% |
Color | Colorless | 100.0% | 100.0% | 100.0% | 100.0% |
13
Results of all combinations | ||||||
---|---|---|---|---|---|---|
Expected Result | Reproducibility | |||||
Repeatability | ||||||
(N=120) | ||||||
(N=240) | ||||||
Analyte | Qualitative | Semi- | ||||
quantitative | ||||||
(mg/dL) | Exact | |||||
match | Within | |||||
+/- 1 BC | Exact | |||||
match | Within | |||||
+/- 1 BC | ||||||
GLU | +3 | 300-500 | 100.0% | 100.0% | 100.0% | 100.0% |
PRO | +3 | 300-600 | 90.8% | 100.0% | 94.6% | 100.0% |
BIL | +3 | 6-10 | 100.0% | 100.0% | 100.0% | 100.0% |
URO | +4 | >12 | 100.0% | 100.0% | 95.8% | 100.0% |
pH | 8.0 | 8.0 | 99.2% | 100.0% | 99.6% | 100.0% |
BLD | +2 | 0.2-0.5 | 100.0% | 100.0% | 100.0% | 100.0% |
KET | +3 | 80-100 | 98.3% | 100.0% | 99.2% | 100.0% |
NIT | +2 | 100.0% | 100.0% | 100.0% | 100.0% | |
LEU | >500 (Leu/μL) | 100.0% | 100.0% | 100.0% | 100.0% | |
TURB | +2 | 100.0% | 100.0% | 100.0% | 100.0% | |
Color | dark yellow | 100.0% | 100.0% | 100.0% | 100.0% |
Table 4. Repeatability and Reproducibility of AUTION MAX AX-4060 Urinalysis System Combined results for Level 2 (High) samples
Table 5. Repeatability and Reproducibility of AUTION MAX AX-4060 Urinalysis System Combined results for Level 3 (Mid) samples
Results of all combinations | |||||||
---|---|---|---|---|---|---|---|
Expected Result | Repeatability | ||||||
(N=120) | Reproducibility | ||||||
(N=240) | |||||||
Analyte | Qualitative | Semi- | |||||
quantitative | |||||||
(mg/dL) | Exact | ||||||
match | Within | ||||||
+/- 1 BC | Exact | ||||||
match | Within | ||||||
+/- 1 BC | |||||||
GLU | +1 | 70-100 | 100.0% | 100.0% | 100.0% | 100.0% | |
PRO | +1 | 30-70 | 100.0% | 100.0% | 100.0% | 100.0% | |
BIL | +2 | 2-4 | 100.0% | 100.0% | 100.0% | 100.0% | |
URO | +2 | 4-6 | 99.2% | 100.0% | 99.2% | 99.6% | |
pH | 6.5 | 6.5 | 100.0% | 100.0% | 100.0% | 100.0% | |
BLD | +1 | 0.06-0.1 | 100.0% | 100.0% | 100.0% | 100.0% | |
KET | +1 | 10-20 | 99.2% | 99.2% | 99.2% | 99.6% | |
NIT | +1 | 100.0% | 100.0% | 100.0% | 100.0% | ||
LEU | 250 (Leu/μL) | 100.0% | 100.0% | 99.2% | 100.0% | ||
TURB | +1 | 100.0% | 100.0% | 100.0% | 100.0% | ||
Color | yellow | 100.0% | 100.0% | 100.0% | 100.0% |
14
Method Comparison
A method comparison study was conducted to evaluate the agreement of results from AUTION MAX AX-4060 Urinalysis System to the FDA-cleared predicate device AUTION MAX AX-4030 Automated Urinalysis System. Testing was performed at two (2) clinical laboratories by using two (2) instruments and two (2) different lots of test strips. A total of 1374 samples, consisting of 1333 natural patient samples and 41 spiked samples, were tested across the sites.
The data from each site was combined and are presented in Table 6 showing percentages of Exact Match and within +/- 1 Color Block Match for all analytes on test strips. Non-test strip items for turbidity and color tone are in the same templates of Table 7 and Table 8 as the test strip analytes.
| Analyte | All
Samples
(n) | Exact
Match
(n) | %
Exact
Match | 95% CI | % +/- 1
CB Match |
|---------|-----------------------|-----------------------|---------------------|---------------|---------------------|
| GLU | 1044 | 1024 | 98.1% | 97.2% - 98.8% | 100.0% |
| PRO | 1048 | 990 | 94.5% | 93.0% - 95.8% | 100.0% |
| BIL | 1338 | 1331 | 99.5% | 99.0% - 99.8% | 100.0% |
| URO | 1341 | 1330 | 99.2% | 98.6% - 99.6% | 100.0% |
| pH | 1063 | 987 | 92.9% | 91.2% - 94.3% | 100.0% |
| BLD | 1044 | 1000 | 95.8% | 94.5% - 96.9% | 100.0% |
| KET | 1336 | 1322 | 99.0% | 98.3% - 99.4% | 100.0% |
| NIT | 1046 | 1043 | 99.7% | 99.3% - 99.9% | 100.0% |
| LEU | 1044 | 1029 | 98.6% | 97.8% - 99.2% | 100.0% |
Table 6. Overall agreement of results for all test analytes between proposed and predicate device
Table 7. Summary table for turbidity
| Analyte | All
Samples
(n) | Exact Match
(n) | % Exact
Match | 95% CI | % +/- 1 CB
Match |
|-----------|-----------------------|--------------------|------------------|-------------|---------------------|
| Turbidity | 1044 | 1029 | 98.6% | 97.8%-99.2% | 100% |
Table 8. Summary table for color tone
Analyte | All Samples (n) | Exact Match (n) | % Exact Match | 95% CI | % +/- 1 CB Match |
---|---|---|---|---|---|
Color tone | 1044 | 863 | 82.7% | 80.3% - 84.9% | 100.0% |
15
Interfering Substances
Evaluation of interfering substances influencing the accuracy of results on AUTION MAX AX-4060 Urinalysis System was conducted with AUTION Sticks 9EB.
A list of interfering substances for a given analyte is provided in Table 9 below. The interfering substances and their highest concentrations tested with no interference are listed in Table 10 below.
16
| Analyte | Substance | Concentration limit with no
significant interference | Effect when above the concentration limit |
|--------------|--------------------|---------------------------------------------------------|---------------------------------------------|
| | Ascorbic Acid | 20 mg/dL | At 50 mg/dL decreased from +2 to +1 |
| Glucose | Urobilinogen | 4 mg/dL | At 8 mg/dL decreased from +2 to +1 |
| | MESNA | 100 mg/dL | At 150 mg/dL increased from NORMAL to +/- |
| | Sodium Bicarbonate | 200 mg/dL | At 250 mg/dL increased from +3 to +4 |
| Protein | Specific Gravity | 1.02 | At 1.025 decreased from +3 to +2 |
| | Hemoglobin | 10 mg/dL | At 12 mg/dL increased from - to +/- |
| Urobilinogen | Bilirubin | 3.5 mg/dL | At 7 mg/dL increased from NORMAL to +1 |
| Blood | Ascorbic Acid | 50 mg/dL | At 100 mg/dL decreased from +2 to +1 |
| | MESNA | 50 mg/dL | At 100 mg/dL decreased from +2 to +1 |
| | Urine pH | pH 8.5 | At pH 9 decreased from +2 to +/- |
| | Methyl-dopa | 50 mg/dL | At 67 mg/dL increased from - to +/- |
| Ketones | MESNA | 1.5 mg/dL | At 3 mg/dL increased from - to +/- |
| | Ascorbic Acid | 50 mg/dL | At 100 mg/dL decreased from +2 to +1 |
| Nitrite | MESNA | 150 mg/dL | At 200 mg/dL decreased from +2 to +1 |
| | Urobilinogen | 5 mg/dL | At 8 mg/dL decreased from +2 to +1 |
| Leukocytes | Bilirubin | 7 mg/dL | At 10.5 mg/dL increased from negative to 25 |
| | Hemoglobin | 3 mg/dL | At 6.25 mg/dL decreased from 250 to 75 |
| | MESNA | 370 mg/dL | At 660 mg/dL decreased from 250 to 75 |
Table 9. Substances interfering with test analytes
Based on the interference testing, following limitations have been included in the labeling:
-
- Elevated hematuria (6.25 mg/dL Hb, approximately 2,156 RBC/uL) has been shown to cause falsely lowered Leukocyte readings and should be considered when interpreting Leukocyte results.
-
- Samples from patients taking methyl dopa may be falsely elevated for blood, negative to trace at 67 mg/dL and negative to +1 at 225 mg/dL. Patients taking the maximum daily dose of methyl dopa may have approximately 210 mg/dL methyl dopa excreted in the urine.
- Patients taking SGLT2 or similar inhibitors may have extremely high urinary glucose values. Due to a 3. hook effect on the glucose pad, if a patient's urine glucose level is greater than 20,000 mg/dL, then falsely decreased glucose results may be obtained with the test.
- When acidic or alkaline compounds, such as ascorbic acid and sodium bicarbonate are taken internally 4. for treatment or as supplements, they may affect urine pH.
17
Interfering Substances | Highest Concentration Tested with No Interference** |
---|---|
Therapeutic drugs | |
Acetaminophen | 40 mg/dL |
Acetoacetic Acid Lithium | 150 mg/dL |
Ammonium Chloride | 400 mg/dL |
Amoxicillin | 360 mg/dL |
Calcium Chloride | 300 mg/dL |
Citric Acid Monohydrate | 75 mg/dL |
Oxalic Acid Dihydrate | 70 mg/dL |
Potassium Chloride | 1000 mg/dL |
Sodium Chloride | 2000 mg/dL |
Sodium Dihydrogen Phosphate | 1000 mg/dL |
Sodium Nitrate | 10 mg/dL |
Sodium Nitrite | 2 mg/dL |
Endogenous substances | |
Albumin | 1000 mg/dL |
Creatinine | 600 mg/dL |
Fructose | 100 mg/dL |
Galactose | 100 mg/dL |
Glucose | 2000 mg/dL |
Glycine | 450 mg/dL |
Lactose | 108 mg/dL |
Low Urine pH | pH 5 |
Riboflavin | 10 mg/dL |
Urea | 3000 mg/dL |
Table 10. Substances with no interference for the highest levels tested
** Not all of the substances tested for interference demonstrated no significant interference for all analytes. For those substances that on initial screening were found to interfere with certain analytes, dose-response testing was conducted to establish the concentration limit below which no significant interference is expected. The results are given in Table 10 above.
18
Limits of Detection and Sensitivity
Limits of detection and Minimum detection sensitivity were determined based on three instruments, and three reagent lots. Listed below in Table 11-14 are the quantitative values indicating the lower limit of the rank in which 50% or more of the results are falling into the specific rank.
Analyte | Minimum detection sensitivity |
---|---|
GLU | 30 mg/dL (+/-) |
PRO | 10 mg/dL (+/-) |
BIL | 0.5 mg/dL (+1) |
URO | 2.0 mg/dL (+1) |
BLD | 0.023 mg/dL (+/-) |
KET | 4.0 mg/dL (+/-) |
NIT | 0.075 mg/dL (+1) |
LEU | 14 Leu/µL |
Table 11. Minimum detection sensitivity
Table 12. Detection sensitivity for each Rank
| | Block
output | Semi-quantitative
rank | Evaluation
Conc.(mg/dL
) | %
Positive |
|-----|-----------------|---------------------------|--------------------------------|---------------|
| GLU | +/- | 30,50 | 30 | 100% |
| | +1 | 70, 100 | 60 | 93% |
| | +2 | 150,200 | 125 | 97% |
| | +3 | 300,500 | 250 | 100% |
| | +4 | 1000,
over | 750 | 100% |
| PRO | +/- | 10, 20 | 10 | 67% |
| | +1 | 30, 70 | 30 | 77% |
| | +2 | 100, 200 | 85 | 53% |
| | +3 | 300, 600 | 250 | 73% |
| | +4 | over | 800 | 93% |
| BIL | +1 | 0.5, 1.0 | 0.5 | 53% |
| | +2 | 2.0, 4.0 | 1.5 | 93% |
| | +3 | 6.0, 10.0 | 5 | 93% |
| | +4 | over | 12 | 93% |
| URO | +1 | 2.0, 3.0 | 2 | 60% |
19
AUTION MAX AX-4060 Urinalysis System K193514
+2 | 4.0, 6.0 | 4 | 80% | |
---|---|---|---|---|
+3 | 8.0, 12.0 | 7 | 100% | |
+4 | over | 14 | 100% | |
BLD | +/- | 0.03 | 0.023 | 100% |
+1 | 0.06, 0.10 | 0.045 | 100% | |
+2 | 0.20, 0.50 | 0.15 | 97% | |
+3 | 1.00, over | 0.75 | 73% | |
KET | +/- | 4 | 97% | |
+1 | 10, 20 | 7.5 | 100% | |
+2 | 40, 60 | 30 | 100% | |
+3 | 80, 100 | 70 | 63% | |
+4 | 150, over | 150 | 100% | |
NIT | +1 | 0.075 | 57% | |
+2 | 0.3 | 100% |
Table 13. Detection sensitivity for each Rank of pH
| | Block
output | Semi-
quantitative
rank | Evaluation
pH | %
Positive |
|----|-----------------|-------------------------------|------------------|---------------|
| pH | 5.5 | 5.5 | 5.3 | 100% |
| | 6 | 6 | 5.8 | 100% |
| | 6.5 | 6.5 | 6.2 | 100% |
| | 7 | 7 | 6.8 | 93% |
| | 7.5 | 7.5 | 7.3 | 80% |
| | 8 | 8 | 8 | 100% |
| | 8.5 | 8.5 | 8.5 | 100% |
| | 9 | 9 | 8.8 | 87% |
20
| | Block
output | Semi-
quantitative
rank | Evaluation
Conc. | %
Positive |
|-----|-----------------|-------------------------------|---------------------|---------------|
| LEU | 25 | 25 | 14 cells/ μ L | 100% |
| | 75 | 75 | 48 cells/ μ L | 70% |
| | 250 | 250 | 172 cells/ μ L | 60% |
| | 500 | 500 | 396 cells/ μ L | 90% |
Linearity
Linearity was evaluated for Non-strip based analytical parameters. Tables 15 and 16 below respectively show the linearity for Color tone and Turbidity.
Color | Exact match |
---|---|
COLORLESS | 100% (54/54) |
BROWN | 100% (54/54) |
ORANGE | 100% (54/54) |
YELLOW | 100% (54/54) |
GREEN | 100% (54/54) |
BLUE | 100% (54/54) |
VIOLET | 100% (54/54) |
RED | 100% (54/54) |
Table 15. Linearity for Color tone
Table 16. Linearity for Turbidity |
---|
----------------------------------- |
Analyte | Rank | Exact match |
---|---|---|
Turbidity | - | 100% (60/60) |
+1 | 100% (60/60) | |
+2 | 100% (60/60) |
Proposed Labeling
Labeling adequately communicates the device's intended use, safety precautions and directions for use. It satisfies 21 CFR Part 809.10 for in vitro diagnostic devices.
Conclusion
The information provided in this 510(k) premarket notification supports that the AUTION MAX AX-4060 Urinalysis System is substantially equivalent to the AUTION MAX AX-4030 Fully-Automated Urinalysis System.